
Results
88
Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.
88 companies
Ouro Fino Saúde Animal Participações
Market Cap: R$1.3b
Engages in the development, production, and sale of veterinary drugs, vaccines, and other products for production and companion animals primarily in Brazil.
OFSA3
R$24.98
7D
1.0%
1Y
14.6%
Sunshine Guojian Pharmaceutical (Shanghai)
Market Cap: CN¥38.9b
A biopharmaceutical company, engages in the research and development, production, and sale of antibody drugs.
688336
CN¥43.09
7D
-8.3%
1Y
28.0%
Quality Chemical Industries
Market Cap: USh584.3b
Engages in the manufactures and sells pharmaceutical drugs in Uganda.
QCIL
USh160.00
7D
0%
1Y
39.1%
Rubicon Research
Market Cap: ₹282.9b
Operates as a specialty pharmaceutical company in India, the United States, and internationally.
RUBICON
₹1,708.80
7D
-5.3%
1Y
n/a
3SBio
Market Cap: HK$44.0b
An investment holding company, engages in the development, production, marketing, and sale of biopharmaceutical products in the People’s Republic of China, the United States, and internationally.
1530
HK$17.66
7D
3.9%
1Y
-41.3%
Orion Oyj
Market Cap: €11.4b
Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.
ORNBV
€80.80
7D
3.1%
1Y
17.0%
JW Pharmaceutical
Market Cap: ₩621.1b
Manufactures and sells medicines and medical supplies in Japan and internationally.
A001060
₩27,350.00
7D
3.2%
1Y
26.6%
JW Holdings
Market Cap: ₩277.5b
Operates as a healthcare company in South Korea, the United States, Japan, China, and internationally.
A096760
₩4,065.00
7D
2.3%
1Y
23.4%
May & Baker Nigeria
Market Cap: ₦63.8b
May & Baker Nigeria Plc, together with its subsidiaries, manufactures, sells, and distributes human pharmaceuticals, human vaccines, and consumer products in Nigeria.
MAYBAKER
₦37.00
7D
0%
1Y
105.0%
PharmaResearch
Market Cap: ₩4.3t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩442,000.00
7D
13.0%
1Y
-37.2%
Procter & Gamble Health
Market Cap: ₹96.8b
Manufactures and markets pharmaceutical and chemical products in India and internationally.
500126
₹5,829.15
7D
-0.07%
1Y
-7.6%
Ajanta Pharma
Market Cap: ₹444.1b
A pharmaceutical formulation company engages in the development, manufacture, and marketing of specialty pharmaceutical finished dosages.
AJANTPHARM
₹3,554.90
7D
-4.1%
1Y
37.8%
Shukra Pharmaceuticals
Market Cap: ₹19.4b
Manufactures and markets pharmaceutical products in India and internationally.
524632
₹44.08
7D
5.7%
1Y
74.9%
Emcure Pharmaceuticals
Market Cap: ₹350.3b
Emcure Pharmaceuticals Limited provide quality and affordable healthcare solutions worldwide.
EMCURE
₹1,846.90
7D
-1.5%
1Y
25.8%
Arab Drug
Market Cap: ج.م3.5b
Engages in the manufacture and sale of pharmaceutical products.
ADCI
ج.م292.58
7D
-0.2%
1Y
82.6%
Incyte
Market Cap: US$25.9b
A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan.
INCY
US$129.72
7D
5.1%
1Y
54.4%
PharmaEssentia
Market Cap: NT$617.5b
A biopharmaceutical company engages in medicine discovery, supplements in developing specialty pharmaceutical reagents, API, and new drug patterns developments in the Americas, Europe, Asia, and Taiwan.
6446
NT$1,585.00
7D
13.2%
1Y
290.2%
Syncom Formulations (India)
Market Cap: ₹16.5b
Manufactures, markets, and sells pharmaceutical formulation products in India and internationally.
524470
₹17.55
7D
12.7%
1Y
4.3%
Vikram Thermo (India)
Market Cap: ₹9.1b
Engages in the manufacture, marketing, and export of pharmaceutical excipients and chemicals in India and internationally.
530477
₹289.15
7D
8.1%
1Y
74.6%
Neuland Laboratories
Market Cap: ₹294.5b
Engages in the manufacture and sale of active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally.
524558
₹22,954.75
7D
-1.6%
1Y
74.3%
KRM Ayurveda
Market Cap: ₹5.7b
Operates a network of hospitals and clinics in India as well as abroad through telemedicine consulting and sales.
KRMAYURVED
₹270.00
7D
-4.2%
1Y
n/a
Trident Lifeline
Market Cap: ₹3.2b
Manufactures and markets finished doses in India, Ghana, Kenya, Peru, Cameroon, Venezuela, and internationally.
543616
₹271.90
7D
-4.2%
1Y
-3.2%
Samsung BiologicsLtd
Market Cap: ₩73.3t
Together with its subsidiaries engages in the manufacturing, commercializing, distributing, and selling of biopharmaceuticals products in South Korea, Europe, the United States, and internationally.
A207940
₩1,590,000.00
7D
3.0%
1Y
1.4%
Quest Laboratories
Market Cap: ₹1.4b
Manufactures and sells pharmaceutical formulations in India.
QUESTLAB
₹86.50
7D
-1.8%
1Y
-12.4%
Merck
Market Cap: Rp1.8t
Engages in the manufacture and sale of pharmaceutical products in Indonesia and internationally.
MERK
Rp3,940.00
7D
0%
1Y
39.7%
Philogen
Market Cap: €960.7m
A biotechnology company, engages in the research and development of drugs for oncology and chronic inflammatory diseases in Italy, Switzerland, the United States, and the European Union.
PHIL
€23.85
7D
1.3%
1Y
1.9%
Acutaas Chemicals
Market Cap: ₹271.3b
Engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally.
ACUTAAS
₹3,313.40
7D
-2.3%
1Y
134.4%
China Regenerative Medicine International
Market Cap: HK$71.5m
Engages in the research, development, production, and sale of tissue engineering and regenerative medicine products in Hong Kong and China.
8158
HK$0.23
7D
11.9%
1Y
-72.4%
Alexandria For Pharmaceuticals & Chemical Industries
Market Cap: ج.م7.8b
Operates as a pharmaceutical company in Egypt.
AXPH
ج.م1,551.61
7D
15.1%
1Y
137.4%
WuXi AppTec
Market Cap: CN¥479.6b
An investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People’s Republic of China, the United States, Europe, and internationally.
603259
CN¥159.06
7D
-3.0%
1Y
66.7%
Shenyang Xingqi PharmaceuticalLtd
Market Cap: CN¥14.1b
Engages in the research, development, production, and sale of ophthalmic drugs in the People’s Republic of China.
300573
CN¥39.94
7D
-0.4%
1Y
-12.6%
Wanbury
Market Cap: ₹9.3b
Manufactures and sells formulations and active pharmaceutical ingredients (API) in India and internationally.
524212
₹267.35
7D
5.0%
1Y
-6.2%
HBM Holdings
Market Cap: HK$14.4b
A biopharmaceutical company, engages in the discovery, development, and commercialization of antibody therapeutics focusing on immunology and oncology in Mainland China, the United States, Europe, and internationally.
2142
HK$16.54
7D
10.1%
1Y
23.4%
SKAN Group
Market Cap: CHF 1.5b
Provides isolators, cleanroom devices, and decontamination processes for pharmaceutical and chemical industries in Europe, the Americas, Asia, and internationally.
SKAN
CHF 65.70
7D
11.4%
1Y
0.6%
ACADIA Pharmaceuticals
Market Cap: US$5.1b
A biopharmaceutical company, focuses on the development and commercialization of medicines for neurological and rare disease in North America.
ACAD
US$30.57
7D
1.3%
1Y
18.9%
AstraZeneca
Market Cap: UK£193.5b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZN
UK£124.76
7D
5.7%
1Y
5.1%